Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy
Completed
- Conditions
- Hodgkin's Lymphoma
- Registration Number
- NCT02404818
- Lead Sponsor
- University of Florida
- Brief Summary
The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
- Completed radiation and chemotherapy treatment for Hodgkin lymphoma involving the mediastinum.
- Patient must be ≥ 18 years at time of consent.
Exclusion Criteria
- Pregnant women at time of Cardiac MRI
- Contraindications to Cardiac MRI (contrast allergy, metal implants, medical devices)
- Glomerular filtration rate (GFR) < 30, unless approved by Radiologist (UF Health Jacksonville Radiology Policy: Administration of Gadolinium-Based Contrast Agents).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiac Abnormalities As Measured By Cardiac MRI Day 1 Cardiac Abnormalities As Measured By Echocardiogram Day 1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Florida Health Proton Therapy Institute
🇺🇸Jacksonville, Florida, United States
University of Florida Health Proton Therapy Institute🇺🇸Jacksonville, Florida, United States